$RVTY News
Last published 1w ago
- 1w agoRVTYREVVITY, INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 8.01 Item 9.01
- 1w agoRVTYQ3 2026 Revvity Earnings Conference Call - REVVITY INCEarnings Call TranscriptsLadies and gentlemen, thank you for joining us, and welcome to the Q3 2026 Revity Earnings Conference Call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question,
- 3w agoRVTYRevvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific WorkflowsBusiness WireAI-first solution bridges workflow coordination gaps and accelerates technology transfer from early discovery through development and manufacturing Multi-tier execution, centralized data and real-time monitoring
- 4w agoRVTYRevvity to Present at Upcoming Investor ConferencesBusiness WireRevvity, Inc. (NYSE:RVTY), today announced it will present at the following investor conferences: 2026 Jefferies Global Healthcare Conference Tuesday, November 17, 2026 8:00 a.m. GMT – Prahlad Singh, president and
- 1mo agoRVTYRevvity to Host Investor DayBusiness WireRevvity, Inc. (NYSE:RVTY), today announced it will host its 2026 Investor Day on Friday, November 13 at 9:00 a.m. ET.Presentations from members of Revvity’s senior management team will provide updates on the Company’s
- 1mo agoRVTYRevvity to Hold Earnings Call on November 3, 2026Business WireRevvity, Inc. (NYSE:RVTY), today announced that it will release its third quarter 2026 financial results prior to market open on Tuesday, November 3, 2026. The Company will host a conference call the same day at 7:30
- 1mo agoRVTYRevvity Launches IVDR-Certified Solution for Early Detection of Type 1 DiabetesBusiness WireFully automated, multiplex autoantibody detection solution, enabling population-wide screening programs DBS-based newborn screening platform enables simple and scalable sample collection Expands Revvity’s
- 1mo agoRVTYRevvity - Morgan Stanley 24th Annual Global Healthcare Conference - REVVITY INCEarnings Call TranscriptsGreat. Welcome, everyone. My name is Mike Padol. I lead our U.S. Life Science Tools and Diagnostics coverage in the healthcare investment banking side at Morgan Stanley. Pleasure to be joined here by Max Kowiak, the CFO
- 2mo agoRVTYRevvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug DiscoveryBusiness WireAcquisition strengthens Revvity’s position in human-relevant life sciences tools for next-generation GLP-1 and GPCR-targeting therapies for metabolic drug discovery Combines HCD’s human pancreatic beta cell models
- 3mo agoRVTYRevvity Announces Financial Results for the Second Quarter of 2026Business WireRevenue of $730 million; pro forma revenue of $711 million; 4% pro forma revenue growth; 3% pro forma organic revenue growth GAAP EPS from continuing operations of $0.48; adjusted EPS from continuing operations of
- 3mo agoRVTYRevvity Board Declares Quarterly DividendBusiness WireThe Board of Directors of Revvity, Inc. (NYSE:RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on November 13, 2026 to all shareholders of record at the
- 3mo agoRVTYRevvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions DisclosureBusiness WireRevvity, Inc. (NYSE:RVTY) today published its 2026 Impact Report, highlighting the Company’s sustainability, social and governance strategy, initiatives and performance. The annual report showcases how the Company
- 4mo agoRVTYRevvity to Hold Earnings Call on Tuesday, August 4, 2026Business WireRevvity, Inc. (NYSE:RVTY), today announced that it will release its second quarter 2026 financial results prior to market open on Tuesday, August 4, 2026. The Company will host a conference call the same day at 7:30
- 4mo agoRVTYRevvity Expands Signals AI Ecosystem Through Anthropic Claude IntegrationBusiness WireNew MCP connector extends Signals AI beyond the Signals One platform, enabling scientists to interact with connected R&D knowledge through Claude Claude accesses scientific data and organizational knowledge
- 4mo agoRVTYRevvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&DBusiness WireScientists can now search, understand and act on complex R&D data in natural language by leveraging leading LLM capabilities within the Signals One platform Governed data and ontology-driven scientific context
- 6mo agoRVTYRevvity Announces Financial Results for the First Quarter of 2026Business WireRevenue of $711 million; pro forma revenue of $687 million; 7% revenue growth; 3% organic growth; 6% pro forma organic growth GAAP EPS from continuing operations of $0.37; adjusted EPS from continuing operations of
- 6mo agoRVTYRevvity Board Declares Quarterly DividendBusiness WireThe Board of Directors of Revvity, Inc. (NYSE:RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 7, 2026 to all shareholders of record at the close
- 6mo agoRVTYRevvity to Present at Upcoming Investor ConferencesBusiness WireRevvity, Inc. (NYSE:RVTY), today announced it will present at the following investor conferences: BofA Securities 2026 Health Care Conference Wednesday, May 13, 2026 9:20 a.m. PT - Steve Willoughby, senior vice
- 7mo agoRVTYRevvity to Hold Earnings Call on Tuesday, May 5, 2026Business WireRevvity, Inc. (NYSE:RVTY), today announced that it will release its first quarter 2026 financial results prior to market open on Tuesday, May 5, 2026. The Company will host a conference call the same day at 7:30 a.m. ET
- 7mo agoRVTYRevvity Unveils its Signals BioDesign Offering to Advance Biologic Research WorkflowsBusiness WireScalable collaboration for biotech and pharma teams: Enables high-throughput construct design (up to 1,000 constructs) with real-time data sharing Integrated, AI-ready biologics ecosystem: Connects design to
- 8mo agoRVTYRevvity to Present at Upcoming Investor ConferencesBusiness WireRevvity, Inc. (NYSE:RVTY), today announced it will present at the following investor conferences: Raymond James 47th Annual Institutional Investors Conference Monday, March 2, 2026 7:30 a.m. ET - Max Krakowiak, senior
- 9mo agoRVTYRevvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026Business WireNew launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight Revvity, Inc. (NYSE:RVTY) announced the launch of multiple new discovery platforms
- 9mo agoRVTYRevvity Announces Financial Results for the Fourth Quarter and Full Year of 2025Business WireFourth quarter revenue of $772 million; 6% revenue growth; 4% organic growth Fourth quarter GAAP EPS of $0.87; Adjusted EPS from continuing operations of $1.70 Initiates full year 2026 guidance Revvity, Inc.
- 10mo agoRVTYRevvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial PerformanceBusiness WireRevvity, Inc. (NYSE:RVTY), today announced that it will release its fourth quarter and full year 2025 financial results prior to market open on Monday, February 2, 2026. The Company will host a conference call the same
- 10mo agoRVTYRevvity to Present at J.P. Morgan Healthcare ConferenceBusiness WireRevvity, Inc. (NYSE:RVTY) will present at the 44th annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 9:45 a.m. PT. President and Chief Executive Officer Prahlad Singh will provide an update on
- 11mo agoRVTYRevvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials DiscoveryBusiness WireNew AI Models-as-a-Service offering to integrate in-silico design with experimental data to continuously improve predictive power and accelerate scientific innovation Revvity, Inc. (NYSE:RVTY) today announced the
- 1y agoRVTYRevvity to Acquire ACD/Labs to Expand its Signals Software CapabilitiesBusiness WireAcquisition deepens Revvity Signals' presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions Revvity, Inc. (NYSE:RVTY), today announced it has entered into
- 1y agoRVTYRevvity to Present at Upcoming Investor ConferencesBusiness WireRevvity, Inc. (NYSE:RVTY), today announced it will present at the following investor conferences: UBS Global Healthcare Conference 2025 Monday, November 10, 2025 8:00 a.m. ET - Max Krakowiak, senior vice president and
- 1y agoRVTYRevvity Announces Financial Results for the Third Quarter of 2025Business WireRevenue of $699 million; 2% reported growth; 1% organic growth GAAP EPS of $0.40; Adjusted EPS from continuing operations of $1.18 Reaffirms full year 2025 organic growth and raises adjusted EPS
- 1y agoRVTYRevvity Board Declares Quarterly DividendBusiness WireThe Board of Directors of Revvity, Inc. (NYSE:RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 6, 2026 to all shareholders of record at the
- 1y agoRVTYRevvity Showcases Progress with Purpose in 2025 Impact ReportBusiness WireAchievements span sustainability, social and governance initiatives Revvity, Inc. (NYSE:RVTY) today released its annual Impact Report, a comprehensive reflection of the Company's sustainability, social and governance
- 1y agoRVTYRevvity to Hold Earnings Call on Monday, October 27, 2025Business WireRevvity, Inc. (NYSE:RVTY), today announced that it will release its third quarter 2025 financial results prior to market open on Monday, October 27, 2025. The Company will host a conference call the same day at 8:00
- 1y agoRVTYSNYRevvity Announces Program to Revolutionize the Early Detection of Type 1 DiabetesBusiness WireInitiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease screening Revvity, Inc. (NYSE:RVTY) today announced a program for expansion of its type 1
- 1y agoRVTYLab Automation Market is Projected To Reach US$8.71 Billion By 2031 at CAGR of 6.3% | The Insight PartnersPR NewswireAccording to a new comprehensive report from The Insight Partners, the global lab automation market is observing significant growth due to...
- 1y agoRVTYRevvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing SystemsBusiness WireCombination of Revvity's proprietary Pin-point platform and Profluent's AI-engineered proteins created to inspire accelerated development of novel gene editing therapies Revvity, Inc. (NYSE:RVTY) announced a strategic
- 1y agoRVTYRevvity, Inc. (RVTY) Presents At Baird 2025 Global Healthcare Conference (Transcript)Earnings Call Transcripts
- 1y agoRVTYRevvity, Inc. (RVTY) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptEarnings Call Transcripts
- 1y agoRVTYRevvity Establishes In Vivo Imaging Center of Excellence in North CarolinaBusiness WireFacility designed to advance the next generation of imaging systems Revvity, Inc. (NYSE:RVTY), today announced the opening of its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina, the heart of
- 1y agoRVTYRevvity to Present at Upcoming Investor ConferencesBusiness WireRevvity, Inc. (NYSE:RVTY), today announced it will present at the following investor conferences: 2025 Wells Fargo Healthcare Conference Wednesday, September 3, 2025 8:00 a.m. ET - Max Krakowiak, senior vice president
- 1y agoRVTYRevvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted TherapeuticsBusiness WireInnovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research Revvity, Inc. (NYSE:RVTY), today announced the launch of pHSense™
- 1y agoRVTYRevvity, Inc. (RVTY) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoRVTYRevvity Announces Financial Results for the Second Quarter of 2025Business WireRevenue of $720 million; 4% reported growth; 3% organic growth GAAP EPS of $0.46; Adjusted EPS from continuing operations of $1.18 Updates full year 2025 guidance Revvity, Inc. (NYSE:RVTY), today reported
- 1y agoRVTYRevvity Board Declares Quarterly DividendBusiness WireThe Board of Directors of Revvity (NYSE:RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on November 7, 2025 to all shareholders of record at the close of
- 1y agoRVTYRevvity to Hold Earnings Call on Monday, July 28, 2025Business WireRevvity, Inc. (NYSE:RVTY), today announced that it will release its second quarter 2025 financial results prior to market open on Monday, July 28, 2025. The Company will host a conference call the same day at 8:00 a.m.
- 1y agoRVTYRevvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing WorkflowsBusiness WireRevvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows Revvity, Inc. (NYSE:RVTY), today announced the
- 1y agoALNTALOTBWARVTYAstroNova Sends Letter to Shareholders Highlighting Growth Strategy and Strength of BoardBusiness WireAstroNova is at critical inflection point in its strategic progress to create meaningful competitive advantages for the Product Identification segment and drive strong, sustainable growth, improved profitability and
- 1y agoRVTYRevvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty TestingBusiness WireThe IDS i20 platform offers fully automated processing of specialty assays in endocrinology, allergy, autoimmune and infectious diseases, Alzheimer's disease and therapeutic drug monitoring Revvity, Inc. (NYSE:RVTY),
- 1y agoRVTYRevvity to Present at Upcoming Investor ConferencesBusiness WireRevvity, Inc. (NYSE:RVTY), today announced it will present at the following investor conferences: Bank of America Global Healthcare Conference 2025 Tuesday, May 13, 2025 9:20 a.m. PT - Max Krakowiak, senior vice
- 1y agoRVTYRevvity Announces Financial Results for the First Quarter of 2025Business WireRevenue of $665 million; 2% reported growth; 4% organic growth GAAP EPS of $0.35; Adjusted EPS from continuing operations of $1.01 Reaffirms full year 2025 organic growth and adjusted EPS guidance Revvity, Inc.
- 1y agoRVTYRevvity Board Declares Quarterly DividendBusiness WireThe Board of Directors of Revvity (NYSE:RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 8, 2025 to all shareholders of record at the close of